Extended Data Fig. 3: Secondary survival outcomes of patients in the intention-to-treat population.
From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
a–c, Kaplan–Meier curves of OS (a), DMFS (b) and LRFS (c) in the RAT group and SOC arm.
